Daniil Gataulin
Stock Analyst at Chardan Capital
(5)
Main Sectors:
Top Industries:
21 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OCUL Ocular Therapeutix | Maintains: Buy | 21 21 | 11.41 | 84.05% | 2 | Oct 2, 2025 | |
ZURA Zura Bio | Maintains: Buy | 10 10 | 3.93 | 154.45% | 2 | Sep 30, 2025 | |
QURE uniQure | Maintains: Strong Buy | 35 76 | 54.92 | 38.38% | 8 | Sep 25, 2025 | |
OCGN Ocugen | Maintains: Buy | 7 7 | 1.77 | 295.48% | 14 | Sep 19, 2025 | |
TRML Tourmaline Bio | Downgrades: Neutral | 70 48 | 47.9 | 0.21% | 4 | Sep 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 10.43 | 398.56% | 13 | Sep 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 3 | 1.06 | 183.02% | 10 | Aug 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 61 61 | 15.49 | 293.8% | 6 | Aug 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 35 | 8.45 | 314.2% | 5 | Aug 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 33 33 | 5.39 | 512.24% | 8 | Aug 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 15 | 8.7 | 72.41% | 7 | Aug 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | 1.55 | 158.06% | 8 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 27 | 13.73 | 96.65% | 12 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Jul 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 33 | 17.57 | 87.82% | 7 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | n/a | n/a | 4 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 0.59 | 37188.14% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |